TerminatedPhase 3NCT05343754

Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum

Studying Classic pyoderma gangrenosum

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Erasmus Medical Center
Principal Investigator: Errol Prens, Prof.Dr.
Erasmus MC, dermatology department
Intervention: Hyperbaric oxygen(drug)
Enrollment: 3 enrolled
Eligibility: 18 years · All sexes
Timeline: 2022 – 2024

Study locations (1)

Erasmus MC, Rotterdam, Netherlands

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05343754 on ClinicalTrials.gov

Other trials for Classic pyoderma gangrenosum

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT06624670
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Boehringer Ingelheim
RECRUITINGPHASE2NCT06563323
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
Oregon Health and Science University

See all trials for Classic pyoderma gangrenosum →

← Back to all trials